The patient has established cardiovascular disease with a documented history of at least one of the following: A) Previous myocardial infarction (MI) B) Previous stroke C) Symptomatic peripheral arterial disease (PAD), evidenced by one of the following: Intermittent claudication with an ankle-brachial index (ABI) less than 0.85 at rest Peripheral arterial revascularization procedure Amputation due to atherosclerotic disease D) Prior revascularization, such as coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or angioplasty, and
Intravenous (IV) Glutathione IV glutathione is administered directly into the bloodstream, bypassing the digestive system entirely and theoretically providing immediate bioavailability
Retatrutide incorporates glucagon receptor agonism into the same molecular framework, engaging a third metabolic pathway that neither mono- nor dual-agonist compounds address
GLP-1 drugs, including Wegovy and similar medications, mimic hormones that regulate appetite and blood sugar, helping patients feel full and eat less
Emmet Kelly: We've got a few minutes
As for free testosterone, the studies by La Vignera et al